This inventor holds 1 USPTO granted patent. Top assignees: Keio University, Sun Pharma Japan Limited. Active years: 2022.
Company Filing History:
1 out of 360 
1 out of 1 Years Active: 2022
Title: Naoyoshi Koike: Innovator in Cancer Research
Introduction
Naoyoshi Koike is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of cancer research, particularly in the development of pharmaceutical solutions aimed at combating cancer stem cells. His innovative approach has the potential to change the landscape of cancer treatment.
Latest Patents
Naoyoshi Koike holds a patent for a cancer stem cell inhibitor. The objective of this invention is to provide a novel pharmaceutical for suppressing cancer stem cells. The active ingredient in this invention is a mitochondria inhibitor comprising a 2-nitroimidazole derivative, which is applied to the cancer stem cell.
Career Highlights
Throughout his career, Naoyoshi Koike has worked with esteemed institutions, including Keio University and Sun Pharma Japan Limited. His work in these organizations has allowed him to collaborate with other experts in the field and further his research endeavors.
Collaborations
Naoyoshi Koike has collaborated with notable individuals such as Oltea Sampetrean and Nobuo Kubota. These partnerships have contributed to the advancement of his research and the development of innovative solutions in cancer treatment.
Conclusion
Naoyoshi Koike's work in cancer research exemplifies the impact of innovation in the medical field. His patent for a cancer stem cell inhibitor showcases his commitment to finding effective treatments for cancer. His contributions are paving the way for future advancements in oncology.